Suppr超能文献

Clinical course of asthma in 4 cases of coronavirus disease 2019 infection.

作者信息

Codispoti Christopher D, Bandi Sindhura, Patel Payal, Mahdavinia Mahboobeh

机构信息

Division of Allergy and Immunology, Department of Internal Medicine Rush University Medical Center, Chicago, Illinois.

Division of Allergy and Immunology, Department of Internal Medicine Rush University Medical Center, Chicago, Illinois.

出版信息

Ann Allergy Asthma Immunol. 2020 Aug;125(2):208-210. doi: 10.1016/j.anai.2020.05.009. Epub 2020 May 11.

Abstract
摘要

相似文献

1
Clinical course of asthma in 4 cases of coronavirus disease 2019 infection.
Ann Allergy Asthma Immunol. 2020 Aug;125(2):208-210. doi: 10.1016/j.anai.2020.05.009. Epub 2020 May 11.
2
COVID-19, severe asthma, and biologics.
Ann Allergy Asthma Immunol. 2020 Sep;125(3):357-359.e1. doi: 10.1016/j.anai.2020.06.012. Epub 2020 Jun 14.
3
Leukotrienes, a potential target for Covid-19.
Prostaglandins Leukot Essent Fatty Acids. 2020 Oct;161:102174. doi: 10.1016/j.plefa.2020.102174. Epub 2020 Sep 17.
4
As a potential treatment of COVID-19: Montelukast.
Med Hypotheses. 2020 Sep;142:109828. doi: 10.1016/j.mehy.2020.109828. Epub 2020 May 11.
5
The Possible Dual Role of the ACE2 Receptor in Asthma and Coronavirus (SARS-CoV2) Infection.
Front Cell Infect Microbiol. 2020 Sep 23;10:550571. doi: 10.3389/fcimb.2020.550571. eCollection 2020.
6
The association between obesity and poor outcome after COVID-19 indicates a potential therapeutic role for montelukast.
Med Hypotheses. 2020 Oct;143:109883. doi: 10.1016/j.mehy.2020.109883. Epub 2020 May 27.
7
Eczema and race as combined determinants for differential response to step-up asthma therapy.
J Allergy Clin Immunol. 2014 Aug;134(2):483-5. doi: 10.1016/j.jaci.2014.03.039. Epub 2014 May 13.
8
COVID-19 in a patient with severe asthma treated with Omalizumab.
Allergy. 2020 Oct;75(10):2705-2708. doi: 10.1111/all.14456. Epub 2020 Jun 27.
9
The QT interval in patients with COVID-19 treated with hydroxychloroquine and azithromycin.
Nat Med. 2020 Jun;26(6):808-809. doi: 10.1038/s41591-020-0888-2.
10
Atopy is predictive of a decreased need for hospitalization for coronavirus disease 2019.
Ann Allergy Asthma Immunol. 2020 Oct;125(4):479-481. doi: 10.1016/j.anai.2020.07.012. Epub 2020 Jul 18.

引用本文的文献

1
Inflammatory and pulmonary function characteristics of bronchial asthma induced by COVID‑19 infection.
Biomed Rep. 2025 Apr 22;22(6):101. doi: 10.3892/br.2025.1979. eCollection 2025 Jun.
2
Lung function before and after COVID-19 in young adults: A population-based study.
J Allergy Clin Immunol Glob. 2022 May;1(2):37-42. doi: 10.1016/j.jacig.2022.03.001. Epub 2022 Mar 30.
3
Symptoms in patients with asthma infected by SARS-CoV-2.
Respir Med. 2021 Aug-Sep;185:106495. doi: 10.1016/j.rmed.2021.106495. Epub 2021 Jun 8.
4
The evidence is in that asthma is not associated with severe coronavirus disease 2019.
Ann Allergy Asthma Immunol. 2021 May;126(5):451-452. doi: 10.1016/j.anai.2021.02.023.
5
Guidance to physicians on managing asthma during the ongoing pandemic.
Lung India. 2021 Mar;38(Supplement):S74-S77. doi: 10.4103/lungindia.lungindia_699_20.
6
Chloroquine and COVID-19: role as a bitter taste receptor agonist?
New Microbes New Infect. 2021 Mar;40:100843. doi: 10.1016/j.nmni.2021.100843. Epub 2021 Jan 24.
7
Asthma exacerbation associated with COVID-19 pneumonia.
Allergol Int. 2021 Jan;70(1):129-130. doi: 10.1016/j.alit.2020.07.002. Epub 2020 Jul 27.
8
Atopy is predictive of a decreased need for hospitalization for coronavirus disease 2019.
Ann Allergy Asthma Immunol. 2020 Oct;125(4):479-481. doi: 10.1016/j.anai.2020.07.012. Epub 2020 Jul 18.
9
Molecular mechanisms and epidemiology of COVID-19 from an allergist's perspective.
J Allergy Clin Immunol. 2020 Aug;146(2):285-299. doi: 10.1016/j.jaci.2020.05.033. Epub 2020 Jul 2.

本文引用的文献

2
Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China.
Allergy. 2020 Jul;75(7):1730-1741. doi: 10.1111/all.14238. Epub 2020 Feb 27.
3
Coronavirus Infections-More Than Just the Common Cold.
JAMA. 2020 Feb 25;323(8):707-708. doi: 10.1001/jama.2020.0757.
4
Prevalence, risk factors, and management of asthma in China: a national cross-sectional study.
Lancet. 2019 Aug 3;394(10196):407-418. doi: 10.1016/S0140-6736(19)31147-X. Epub 2019 Jun 20.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验